1h Free Analyst Time
The publisher has been monitoring the ligases enzyme market and it is poised to grow by $ 5.15 bn during 2022-2026, progressing at a CAGR of 11.05% during the forecast period. The report on the ligases enzyme market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing need for ligases in disease treatment and the increased use of ligases enzyme by biotechnology and pharmaceutical companies.
The ligases enzyme market analysis includes the source segment and geographic landscape.
The ligases enzyme market is segmented as below:
By Source
- Microorganism
- Animal
- Plant
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increase in research and development activities for sequencing applications as one of the prime reasons driving the ligases enzyme market growth during the next few years.
The report on ligases enzyme market covers the following areas:
- Ligases enzyme market sizing
- Ligases enzyme market forecast
- Ligases enzyme market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ligases enzyme market vendors that include Agilent Technologies Inc., ArcticZymes Technologies ASA, BASF SE, Merck KGaA, New England Biolabs Inc., Novo Holdings AS, Promega Corp., QIAGEN NV, Takara Bio Inc., and Thermo Fisher Scientific Inc. Also, the ligases enzyme market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Source
- Market segments
- Comparison by Source
- Microorganism - Market size and forecast 2021-2026
- Animal - Market size and forecast 2021-2026
- Plant - Market size and forecast 2021-2026
- Market opportunity by Source
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc.
- ArcticZymes Technologies ASA
- BASF SE
- Merck KGaA
- New England Biolabs Inc.
- Novo Holdings AS
- Promega Corp.
- QIAGEN NV
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Source - Market share 2021-2026 (%)
- Comparison by Source
- Microorganism - Market size and forecast 2021-2026 ($ million)
- Microorganism - Year-over-year growth 2021-2026 (%)
- Animal - Market size and forecast 2021-2026 ($ million)
- Animal - Year-over-year growth 2021-2026 (%)
- Plant - Market size and forecast 2021-2026 ($ million)
- Plant - Year-over-year growth 2021-2026 (%)
- Market opportunity by Source
- Customer landscape
- Market share By Geographical Landscape 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Key customers
- Agilent Technologies Inc. - Segment focus
- ArcticZymes Technologies ASA - Overview
- ArcticZymes Technologies ASA - Business segments
- ArcticZymes Technologies ASA - Key offerings
- ArcticZymes Technologies ASA - Key customers
- ArcticZymes Technologies ASA - Segment focus
- BASF SE - Overview
- BASF SE - Business segments
- BASF SE - Key offerings
- BASF SE - Key customers
- BASF SE - Segment focus
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key offerings
- Merck KGaA - Key customers
- Merck KGaA - Segment focus
- New England Biolabs Inc. - Overview
- New England Biolabs Inc. - Product and service
- New England Biolabs Inc. - Key offerings
- New England Biolabs Inc. - Key customers
- New England Biolabs Inc. - Segment focus
- Novo Holdings AS - Overview
- Novo Holdings AS - Product and service
- Novo Holdings AS - Key offerings
- Novo Holdings AS - Key customers
- Novo Holdings AS - Segment focus
- Promega Corp. - Overview
- Promega Corp. - Product and service
- Promega Corp. - Key offerings
- Promega Corp. - Key customers
- Promega Corp. - Segment focus
- QIAGEN NV - Overview
- QIAGEN NV - Business segments
- QIAGEN NV - Key offerings
- QIAGEN NV - Key customers
- QIAGEN NV - Segment focus
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Business segments
- Takara Bio Inc. - Key offerings
- Takara Bio Inc. - Key customers
- Takara Bio Inc. - Segment focus
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Key customers
- Thermo Fisher Scientific Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global ligases enzyme market: Agilent Technologies Inc., ArcticZymes Technologies ASA, BASF SE, Merck KGaA, New England Biolabs Inc., Novo Holdings AS, Promega Corp., QIAGEN NV, Takara Bio Inc., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increase in research and development activities for sequencing applications.`
According to the report, one of the major drivers for this market is the growing need for ligases in disease treatment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- ArcticZymes Technologies ASA
- BASF SE
- Merck KGaA
- New England Biolabs Inc.
- Novo Holdings AS
- Promega Corp.
- QIAGEN NV
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
